Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Fatigue Cracking Resistance of Crumb Rubber-Modified Asphalt: Mechanisms, Testing Methods, and Multiscale Performance Evaluation from Binder to Field.

Created on 16 Oct 2026

Authors

Anil Rai, Sushmit Sharma Bhattarai, Hyunhwan Kim, Moon-Sup Lee, Soon-Jae Lee

Published in

Polymers. Volume 18. Issue 19. Oct 08, 2026. Epub Oct 08, 2026.

Abstract

Fatigue cracking is a load-related distress limiting flexible pavement service life. This review evaluates 121 studies on the fatigue resistance of crumb rubber-modified asphalt (CRMA) across binder, mixture, modeling, and field scales. CRMA improves fatigue resistance through rubber-asphalt interaction and the elastic contribution of undissolved particles; adequate swelling, dispersion, and bonding slow crack propagation, whereas weak interaction or aging-related interface weakening promotes localized damage. Optimum rubber contents and particle sizes vary with damage stage, material scale, dosage basis, and processing. The benefit is strain-dependent, greater at 2.5% than 5.0%, and rankings may reverse between amplitudes. Linear viscoelastic parameters poorly characterize progressive damage in highly modified binders; linear amplitude sweep testing with viscoelastic continuum damage analysis is more informative but sensitive to the failure criterion. The benefit narrows with evaluation scale, though not uniformly: binder-level improvements reach 116 times the control at 2.5% strain and 45 times at 5.0%, mixture-scale improvements about 1.4 to 10 times (upper bound provisional), and field performance comparable to or moderately better than modified controls. CRMA is a viable alternative to polymer-modified asphalt under specific conditions; equivalence rather than superiority is defensible. Standardized failure criteria, phase-resolved aging procedures, protocols representing healing, and validated multi-scale relationships are needed.

PMID:
42885082
Bibliographic data and abstract were imported from PubMed on 16 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 20
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement